News

BeiGene announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorizations for BRUKINSA (zanubrutinib) in Great Britain for both the…
Read More...

Advaxis, Inc., a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered Listeria monocytogenes …
Read More...

Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or associated companies, "Sun Pharma") and Concert Pharmaceuticals, Inc. announced that they have executed a…
Read More...

EVOQ Therapeutics announced the advancement of their ongoing license and collaboration agreement with Amgen for the discovery and development of novel therapeutics including the receipt…
Read More...

Avidity Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AOC 1020 for the treatment of facioscapulohumeral muscular…
Read More...

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner SK bioscience has…
Read More...

APRINOIA Therapeutics Inc. ("APRINOIA"), a clinical-stage biotechnology company focused on neurodegenerative diseases such as Alzheimer's Disease ("AD") and Progressive Supranuclear…
Read More...

Forge Biologics announced that the European Medicines Agency (EMA) has granted priority medicines (PRIME) designation to FBX-101, Forge’s lead adeno-associated virus (AAV) drug…
Read More...

Perceiv AI announced that the company has been selected by Merck for the inaugural Merck Digital Sciences Studio (MDSS) cohort, along with eight other early-stage biomedical startups…
Read More...

Amylyx Pharmaceuticals, Inc. announced it has entered into an exclusive license and distribution agreement with Neopharm in which Neopharm will commercialize, subject to regulatory…
Read More...

AffaMed Therapeutics, a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in neurological, psychiatric and ophthalmic disorders announced…
Read More...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that the U.S. Patent and Trademark…
Read More...

Orphagen Pharmaceuticals, Inc., a biotech company pioneering the screening, discovery, and development of small molecule ligands that modulate orphan or unexplored members of the…
Read More...

CARsgen Therapeutics Holdings Limited and Huadong Medicine announced a collaboration for the commercialization of CARsgen's BCMA CAR-T product CT053 in mainland China. CT053,…
Read More...

Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company, announced that the China National Medical Products Administration (NMPA) has approved BAT1806, a biosimilar of…
Read More...

Roche announced that the European Commission (EC) has approved Xofluza (baloxavir marboxil) in children aged one year and above for the treatment of uncomplicated influenza and for…
Read More...

The Sabin Vaccine Institute announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to…
Read More...

AstraZeneca’s Tezspire (tezepelumab) has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) for self-administration in…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered an option and research collaboration agreement with Monash University (Melbourne, Victoria, Australia) to discover and develop…
Read More...

Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, announced that the U.S. Food and…
Read More...